Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Fanbin Meng

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113222590. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper

Papers 3

  1. Silencing of ATF2 inhibits growth of pancreatic cancer cells and enhances sensitivity to chemotherapy. Co-author DOI 10.1002/cbin.10760↗
  2. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ijo.2014.2794↗
  3. Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migra… Co-author DOI 10.1002/iub.1336↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shaowei Song · 3 shared papers, 2014–2017 · strength 0.19
  2. Kejian Guo · 2 shared papers, 2014–2015 · strength 0.11
  3. Xingda Wu · 1 shared paper, 2017 · strength 0.08
  4. Mu Li · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.